BioCentury
ARTICLE | Company News

Asuragen, J&J deal

September 22, 2014 7:00 AM UTC

Johnson & Johnson's Janssen Diagnostics LLC subsidiary gained worldwide rights to offer next-generation sequencing services to researchers using Asuragen's SuraSeq platform. J&J said financial terms a...